Cancer Incidence and Mortality among White Individuals, New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 23,454.0 439.5 437.0-442.1 11,340.0 468.9 465.0-472.9 12,114.0 425.6 422.1-429.2 6,800.8 120.7 119.4-122.0 3,337.0 139.7 137.5-141.8 3,463.8 108.0 106.4-109.7
Oral cavity and pharynx 530.4 9.8 9.5-10.2 357.0 14.6 13.9-15.3 173.4 5.8 5.5-6.3 109.8 2.0 1.8-2.2 75.6 3.1 2.8-3.5 34.2 1.1 0.9-1.3
Esophagus 182.8 3.3 3.1-3.5 134.4 5.5 5.1-5.9 48.4 1.5 1.3-1.7 130.8 2.3 2.2-2.5 100.6 4.1 3.8-4.5 30.2 0.9 0.8-1.1
Stomach 445.6 8.4 8.0-8.7 251.0 10.6 10.0-11.2 194.6 6.7 6.2-7.1 205.6 3.8 3.5-4.0 124.4 5.2 4.8-5.7 81.2 2.7 2.4-2.9
Colorectal 1,876.8 35.1 34.4-35.8 989.8 41.4 40.3-42.6 887.0 30.0 29.1-30.9 634.6 11.3 10.9-11.7 324.0 13.6 13.0-14.3 310.6 9.4 9.0-10.0
Colon excluding rectum 1,333.4 24.7 24.1-25.3 683.0 28.6 27.6-29.6 650.4 21.5 20.8-22.3 510.6 9.0 8.6-9.4 256.0 10.7 10.2-11.4 254.6 7.7 7.3-8.1
Rectum & rectosigmoid 543.4 10.4 10.0-10.8 306.8 12.8 12.2-13.5 236.6 8.4 8.0-9.0 124.0 2.3 2.1-2.5 68.0 2.9 2.6-3.2 56.0 1.8 1.5-2.0
Liver / intrahepatic bile duct 510.2 9.2 8.8-9.5 356.0 14.3 13.6-14.9 154.2 4.9 4.6-5.3 324.4 5.8 5.5-6.1 208.0 8.5 8.0-9.0 116.4 3.6 3.3-3.9
Pancreas 763.6 13.7 13.2-14.1 376.0 15.6 14.8-16.3 387.6 12.1 11.5-12.7 582.4 10.2 9.9-10.6 287.0 11.9 11.3-12.6 295.4 8.9 8.4-9.4
Larynx 138.6 2.5 2.4-2.8 110.2 4.5 4.1-4.9 28.4 1.0 0.8-1.2 44.2 0.8 0.7-0.9 37.6 1.5 1.3-1.8 6.6 0.2 0.1-0.3
Lung and bronchus 2,497.0 44.8 44.0-45.6 1,197.4 49.7 48.5-51.0 1,299.6 41.4 40.4-42.5 1,289.6 22.7 22.2-23.3 660.8 27.6 26.6-28.5 628.8 19.2 18.5-19.9
Melanoma of the skin 832.0 15.6 15.2-16.1 469.2 19.7 18.9-20.6 362.8 12.8 12.2-13.4 73.0 1.3 1.2-1.5 43.2 1.8 1.6-2.1 29.8 0.9 0.8-1.1
Female breast             3,542.2 130.2 128.2-132.2             539.4 17.4 16.7-18.1
Cervix uteri             179.8 7.2 6.7-7.7             47.8 1.8 1.5-2.0
Corpus uterus and NOS             837.4 29.2 28.3-30.1             171.8 5.5 5.1-5.8
Ovary             307.6 11.0 10.5-11.6             195.8 6.3 5.9-6.8
Prostate       2,693.4 107.1 105.3-109.0             335.2 14.2 13.5-14.9      
Testis       167.6 7.1 6.6-7.6             4.4 0.2 0.1-0.3      
Urinary bladder (incl. in situ) 1,097.0 19.6 19.1-20.1 815.0 34.1 33.0-35.1 282.0 8.9 8.5-9.4 204.0 3.4 3.2-3.7 138.8 5.9 5.4-6.3 65.2 1.9 1.7-2.1
Kidney and renal pelvis 801.0 15.3 14.8-15.8 525.2 21.9 21.0-22.7 275.8 9.8 9.3-10.4 132.6 2.4 2.2-2.6 86.6 3.6 3.3-4.0 46.0 1.4 1.2-1.6
Brain and other central nervous system 333.4 6.8 6.5-7.1 185.8 8.0 7.5-8.6 147.6 5.7 5.3-6.1 195.4 3.7 3.5-4.0 107.6 4.5 4.1-4.9 87.8 3.0 2.7-3.3
Thyroid 986.4 20.6 20.0-21.2 257.2 11.0 10.4-11.6 729.2 30.1 29.1-31.1 28.2 0.5 0.4-0.6 10.0 0.4 0.3-0.6 18.2 0.5 0.4-0.7
Hodgkin lymphoma 149.4 3.2 2.9-3.4 82.6 3.6 3.3-4.0 66.8 2.8 2.5-3.1 15.2 0.3 0.2-0.3 9.4 0.4 0.3-0.5 5.8 0.2 0.1-0.3
Non-Hodgkin lymphomas 1,171.0 22.1 21.5-22.6 620.2 26.2 25.3-27.1 550.8 18.8 18.0-19.5 268.2 4.7 4.5-5.0 148.0 6.3 5.8-6.7 120.2 3.6 3.3-3.9
Myeloma 395.4 7.2 6.9-7.5 219.8 9.1 8.5-9.6 175.6 5.8 5.4-6.2 133.8 2.3 2.1-2.5 74.4 3.1 2.8-3.4 59.4 1.8 1.6-2.0
Leukemias 799.4 15.3 14.8-15.8 458.8 19.6 18.8-20.5 340.6 11.8 11.3-12.4 292.8 5.3 5.0-5.6 155.4 6.6 6.2-7.1 137.4 4.3 4.0-4.7

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.